Ads
related to: patent infringement, federal court- Contact us
Contact us for Free Consultation
US Trademark Forum®
- Comprehansive Search
Get Your Trademark
Searched and Secured
- FAQs
Any confusion?
We’ve got the expertise to answer!
- Office Action Response
It’s Time to Take Action!
Contact US Trademark Forum®
- Trademark Registration
Protect Your Brand Identity
with Trademark Registration
- About us
US Trademark Forum equips business
equips businesses with the tools
- Contact us
Search results
Federal Court of Appeal upholds invalidity of Lilly’s CIALIS patent extending to "physiologically...
JD Supra· 1 day agoCourt of Appeal (FCA) dismissed an appeal by Lilly from a decision of the Federal Court (see our previous article) which had granted a motion for summary ...
Infringement Judgement Is Only Final When There’s Nothing Left to Do but Execute | JD Supra
JD Supra· 3 days agoPacket sued NetScout in the Eastern District of Texas for infringing various patents. Previously, the district court found that NetScout willfully infringed ...
Getting to the Core of It: Assignment Clause Is Ambiguous | JD Supra
JD Supra· 2 days agoCore Optical filed complaints against three groups of defendants alleging patent infringement. The lead defendant, Nokia, moved for summary judgment, arguing ...
Generic-Drug Disputes Fuel New Jersey's Surge in Patent Litigation\t\t | New Jersey Law Journal
Law.com· 2 days agoNew Jersey’s federal courts are in the midst of a surge in patent litigation, driven by pharmaceutical companies’ claims of infringement against generic-drug ...
No Attorneys’ Fees Available for Successful IPR in Parallel Court Proceedings
The National Law Review· 2 days agoDish Network L.L.C., Case Nos. 2022-1621; -1777; -1622; -1779 (Fed. Cir.
Pfizer Files Flurry of Lawsuits Over Migraine Medication Patent | Delaware Law Weekly
Law.com· 4 days agoPfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication ...
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - May 2024 | JD Supra
JD Supra· 1 day agoThis is the first time that the Second Circuit has considered a claim under the Supreme Court’s 2013 Actavis decision, which found that patent ...
Patent Case Summaries | Week Ending May 24, 2024 | JD Supra
JD Supra· 3 days agoLKQ Corp., et al. v. GM Global Technology Operations LLC, No. 2021-2348 (Fed. Cir. In this appeal, the Federal Circuit sat en banc to address the standards for assessing obviousness ...
2023 Highlights in Canadian Life Sciences IP and Regulatory Law | JD Supra
JD Supra· 2 days agoThe FC found the third patent claiming an aqueous formulation of adalimumab valid, with infringement conceded, but declined to grant a permanent injunction ...
Ambiguous Phrase in a Patent Assignment Precludes Summary Judgment Regarding Standing | JD Supra
JD Supra· 2 days agoSummary: Applying California law, the phrase “entirely on my own time” in an employment agreement was found ambiguous and therefore precluded summary judgment of no standing to sue for
Ad
related to: patent infringement, federal court